福元医药(601089.SH)：地屈孕酮片获药品注册证书

Core Viewpoint - The company has received approval for the production of Dydrogesterone tablets (10mg) from the National Medical Products Administration, indicating a significant regulatory milestone for the company [1] Group 1: Company Information - The full subsidiary of the company, Zhejiang Aisheng Pharmaceutical Co., Ltd., is responsible for the production of Dydrogesterone tablets [1] - Dydrogesterone is classified as an orally absorbable synthetic progestogen, which may expand the company's product offerings in the hormonal therapy market [1]